First Time Loading...

Immunovant Inc
NASDAQ:IMVT

Watchlist Manager
Immunovant Inc Logo
Immunovant Inc
NASDAQ:IMVT
Watchlist
Price: 30.48 USD 2.01%
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

711.4m
+144%
Assets
Growth Rates:
1 Year
+56%
3 Years
+64%
5 Years
-
7 Years
-
10 Years
-
32.1m
-20%
Liabilities
Growth Rates:
1 Year
-23%
3 Years
+70%
5 Years
-
7 Years
-
10 Years
-
679.3m
+170%
Equity
Growth Rates:
1 Year
+64%
3 Years
+64%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Immunovant Inc

711.4m
Assets
32.1m
Liabilities
711.4m
Assets
32.1m
Liabilities
Current Assets 710.8m
Cash & Short-Term Investments 690.9m
Receivables 1m
Other Current Assets 18.8m
Non-Current Assets 670k
PP&E 670k
Current Liabilities 32.1m
Accounts Payable 3.9m
Accrued Liabilities 28.2m

Balance Sheet
Immunovant Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
0
101
400
494
377
Cash
0
101
400
494
377
Total Receivables
0
3
1
13
1
Accounts Receivables
0
0
0
12
1
Other Receivables
0
0
0
1
0
Other Current Assets
0
6
8
6
27
Total Current Assets
0
109
409
513
404
PP&E Net
0
0
4
3
2
Other Long-Term Assets
0
0
0
0
0
Total Assets
0
N/A
109
+27 250%
413
+277%
516
+25%
406
-21%
Liabilities
Accounts Payable
0
1
2
19
1
Accrued Liabilities
0
11
16
26
42
Short-Term Debt
0
0
0
0
0
Other Current Liabilities
0
3
0
0
0
Total Current Liabilities
0
15
19
45
43
Long-Term Debt
0
0
0
0
0
Other Liabilities
0
0
2
1
0
Total Liabilities
0
N/A
15
+3 725%
21
+37%
46
+118%
43
-5%
Equity
Common Stock
0
0
0
0
0
Retained Earnings
0
91
199
355
566
Additional Paid In Capital
0
185
590
825
928
Other Equity
0
0
0
0
1
Total Equity
0
N/A
94
N/A
392
+316%
470
+20%
363
-23%
Total Liabilities & Equity
0
N/A
109
+27 250%
413
+277%
516
+25%
406
-21%
Shares Outstanding
Common Shares Outstanding
13
57
98
117
130

See Also

Summary
IMVT intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMVT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMVT stock valuation using valuation multiples.
Wall Street Estimates
IMVT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMVT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.